Text stringlengths 636 34.6k |
|---|
Drug A is Buspirone. Drug B is Bacitracin. The severity of the interaction is minor. Bacitracin may decrease the excretion rate of Buspirone which could result in a higher serum level. The subject drug is a nephrotoxic agent that may potentially impair renal function and decrease the excretion of drugs that mainly unde... |
Drug A is Buspirone. Drug B is Baclofen. The severity of the interaction is minor. Baclofen may increase the central nervous system depressant (CNS depressant) activities of Buspirone. Baclofen possesses CNS depressant effects and can cause drowsiness and sedation, which may be an additive when used concomitantly with ... |
Drug A is Buspirone. Drug B is Balsalazide. The severity of the interaction is minor. The risk or severity of hypertension can be increased when Buspirone is combined with Balsalazide. Concurrent use of drugs known to increase blood pressure is expected to result in an increased risk for supine hypertension. Closely mo... |
Drug A is Buspirone. Drug B is Baricitinib. The severity of the interaction is minor. Buspirone may decrease the excretion rate of Baricitinib which could result in a higher serum level. The renal excretion of drugs is the overall result of a combination of kidney processes that include glomerular filtration, passive d... |
Drug A is Buspirone. Drug B is Beclomethasone dipropionate. The severity of the interaction is moderate. The metabolism of Buspirone can be increased when combined with Beclomethasone dipropionate. The subject is an inducer of the CYP3A5 enzyme, and the affected drug is a substrate of the CYP3A5 enzyme. When these drug... |
Drug A is Buspirone. Drug B is Benazepril. The severity of the interaction is minor. Buspirone may decrease the antihypertensive activities of Benazepril. The subject drug is known to produce hypertension, this effect can be achieved by different mechanisms. As a consequence, if this agent is used in combination with a... |
Drug A is Buspirone. Drug B is Benperidol. The severity of the interaction is moderate. The risk or severity of CNS depression can be increased when Buspirone is combined with Benperidol. Central nervous system (CNS) depressants can cause sedation, falls, respiratory depression, coma, and death. 2,3 The potential inter... |
Drug A is Buspirone. Drug B is Benzatropine. The severity of the interaction is moderate. The risk or severity of adverse effects can be increased when Buspirone is combined with Benzatropine. Reports have indicated that concomitant administration of benzatropine and inhibitors of dopamine activity can increase gastroi... |
Drug A is Buspirone. Drug B is Benznidazole. The severity of the interaction is minor. Buspirone may decrease the excretion rate of Benznidazole which could result in a higher serum level. The renal excretion of drugs is the overall result of a combination of kidney processes that include glomerular filtration, passive... |
Drug A is Buspirone. Drug B is Benzocaine. The severity of the interaction is moderate. The risk or severity of CNS depression can be increased when Buspirone is combined with Benzocaine. Central nervous system (CNS) depressants can cause sedation, falls, respiratory depression, coma, and death. 2,3 The potential inter... |
Drug A is Buspirone. Drug B is Benzphetamine. The severity of the interaction is moderate. The risk or severity of CNS depression can be increased when Buspirone is combined with Benzphetamine. Central nervous system (CNS) depressants can cause sedation, falls, respiratory depression, coma, and death. 2,3 The potential... |
Drug A is Buspirone. Drug B is Benzydamine. The severity of the interaction is minor. The risk or severity of hypertension can be increased when Buspirone is combined with Benzydamine. Concurrent use of drugs known to increase blood pressure is expected to result in an increased risk for supine hypertension. Closely mo... |
Drug A is Buspirone. Drug B is Benzyl alcohol. The severity of the interaction is moderate. The risk or severity of CNS depression can be increased when Buspirone is combined with Benzyl alcohol. Central nervous system (CNS) depressants can cause sedation, falls, respiratory depression, coma, and death. 2,3 The potenti... |
Drug A is Buspirone. Drug B is Bepotastine. The severity of the interaction is minor. Buspirone may decrease the excretion rate of Bepotastine which could result in a higher serum level. The renal excretion of drugs is the overall result of a combination of kidney processes that include glomerular filtration, passive d... |
Drug A is Buspirone. Drug B is Berotralstat. The severity of the interaction is moderate. The metabolism of Buspirone can be decreased when combined with Berotralstat. The subject drug is a moderate CYP2D6 inhibitor and the affected drug is metabolized by CYP2D6. Concomitant administration may decrease the metabolism o... |
Drug A is Buspirone. Drug B is Betamethasone. The severity of the interaction is minor. The metabolism of Buspirone can be increased when combined with Betamethasone. The subject is a weak inducer of the CYP3A5 enzyme, and the affected drug is a substrate of the CYP3A5 enzyme. When these drugs are administered concomit... |
Drug A is Buspirone. Drug B is Betaxolol. The severity of the interaction is minor. Buspirone may decrease the antihypertensive activities of Betaxolol. The subject drug is known to produce hypertension, this effect can be achieved by different mechanisms. As a consequence, if this agent is used in combination with ant... |
Drug A is Buspirone. Drug B is Bicisate. The severity of the interaction is minor. Buspirone may decrease the excretion rate of Bicisate which could result in a higher serum level. The renal excretion of drugs is the overall result of a combination of kidney processes that include glomerular filtration, passive diffusi... |
Drug A is Buspirone. Drug B is Bimekizumab. The severity of the interaction is moderate. The metabolism of Buspirone can be increased when combined with Bimekizumab. The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine lev... |
Drug A is Buspirone. Drug B is Biperiden. The severity of the interaction is moderate. The metabolism of Buspirone can be decreased when combined with Biperiden. The subject drug is known to be an inhibitor of CYP2D6 while the affected drug is reported to be metabolized by CYP2D6. Concomitant administration of these ag... |
Drug A is Buspirone. Drug B is Bismuth subgallate. The severity of the interaction is minor. Buspirone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level. The renal excretion of drugs is the overall result of a combination of kidney processes that include glomerular filtrat... |
Drug A is Buspirone. Drug B is Bisoprolol. The severity of the interaction is minor. Buspirone may decrease the antihypertensive activities of Bisoprolol. The subject drug is known to produce hypertension, this effect can be achieved by different mechanisms. As a consequence, if this agent is used in combination with a... |
Drug A is Buspirone. Drug B is Bleomycin. The severity of the interaction is minor. Bleomycin may decrease the excretion rate of Buspirone which could result in a higher serum level. The renal excretion of drugs is the overall result of a combination of kidney processes that include glomerular filtration, passive diffu... |
Drug A is Buspirone. Drug B is Bortezomib. The severity of the interaction is minor. The metabolism of Buspirone can be decreased when combined with Bortezomib. Both of these drugs are metabolized by CYP2D6. Concomitant administration of these agents may produce a decrease in the metabolic rate of one or both drugs as ... |
Drug A is Buspirone. Drug B is Bosentan. The severity of the interaction is minor. Buspirone may decrease the antihypertensive activities of Bosentan. The subject drug is known to produce hypertension, this effect can be achieved by different mechanisms. As a consequence, if this agent is used in combination with antih... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.